Skip to main content
Biorasis gets $3M boost

Biorasis, which is developing the Glucowizzard minimally invasive biosensor for monitoring glucose in patients with diabetes, has secured $3 million from The Leona M. and Harry B. Helmsley Charitable Trust. The money "fills a critical need in financing that will enable Biorasis to move our technology forward to be ready for clinical trials," said Chief Operating Officer Ilze Krisst.

Full Story: